Introduction of a PCT-based algorithm to guide antibiotic prescription in COPD exacerbation

Area of Science:

• Pulmonology
• Infectious Diseases
• Biomarkers

Background:

• Antibiotic prescribing for COPD exacerbations is challenging.
• Procalcitonin (PCT) is a biomarker that can help reduce antibiotic use.
• Optimal PCT cut-off levels for guiding therapy are often unclear.

Purpose of the Study:

• To assess the impact of a PCT-based algorithm on antibiotic prescription rates in COPD exacerbations.
• To evaluate the effectiveness of a standardized PCT protocol in clinical practice.

Main Methods:

• An observational, retrospective, before-and-after study design was employed.
• Physician practices for PCT testing and antibiotic prescription were reviewed.
• Antibiotic prescription rates were compared before and after protocol implementation.

Main Results:

• Antibiotic prescriptions decreased by 41% post-protocol (59% vs. 35%, P<0.001).
• No significant increase in morbidity or mortality at Day 30 was observed.
• Neither antibiotic duration nor hospital stay length changed significantly.

Conclusions:

• Hospital physicians can effectively use PCT-based algorithms to guide antibiotic prescribing in COPD exacerbations.
• Disseminating information on appropriate PCT cut-off levels is effective in reducing antibiotic prescriptions.
• Clarifying PCT use is crucial for managing antibiotic exposure in these patients.